Elizabeth Grimm
Elizabeth Grimm
Professor, University of Texas MD Anderson Cancer Center
Verified email at
Cited by
Cited by
Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
EA Grimm, A Mazumder, HZ Zhang, SA Rosenberg
The Journal of experimental medicine 155 (6), 1823-1841, 1982
Integrative analysis identifies four molecular and clinical subsets in uveal melanoma
AG Robertson, J Shih, C Yau, EA Gibb, J Oba, KL Mungall, JM Hess, ...
Cancer cell 32 (2), 204-220. e15, 2017
Biological Activity of Recombinant Human Interleukin-2 Produced in Escherichia coli
SA Rosenberg, EA Grimm, M McGrogan, M Doyle, E Kawasaki, K Koths, ...
Science 223 (4643), 1412-1415, 1984
Induction of Chemosensitivity in Human Lung Cancer Cells in Vivo by Adenovirus-mediated Transfer of the Wild-Type p53 Gene
T Fujiwara, EA Grimm, T Mukhopadhyay, WW Zhang, LB Owen-Schaub, ...
Cancer research 54 (9), 2287-2291, 1994
Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor
MT Lotze, EA Grimm, A Mazumder, JL Strausser, SA Rosenberg
Cancer Research 41 (11_Part_1), 4420-4425, 1981
The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses
SF Hussain, D Yang, D Suki, K Aldape, E Grimm, AB Heimberger
Neuro-oncology 8 (3), 261-279, 2006
Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and …
EA Grimm, KM Ramsey, A Mazumder, DJ Wilson, JY Djeu, SA Rosenberg
The Journal of experimental medicine 157 (3), 884-897, 1983
Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells.
EA Grimm, RJ Robb, JA Roth, LM Neckers, LB Lachman, DJ Wilson, ...
The Journal of experimental medicine 158 (4), 1356-1361, 1983
DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement
LB Owen-Schaub, S Yonehara, WL Crump III, EA Grimm
Cellular Immunology 140 (1), 197-205, 1992
The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24
EG Caudell, JB Mumm, N Poindexter, S Ekmekcioglu, AM Mhashilkar, ...
The Journal of immunology 168 (12), 6041-6046, 2002
Uveal melanoma: From diagnosis to treatment and the science in between
C Chattopadhyay, DW Kim, DS Gombos, J Oba, Y Qin, MD Williams, ...
Cancer 122 (15), 2299-2312, 2016
Oncogenic BRAF (V600E) promotes stromal cell-mediated immunosuppression via induction of interleukin-1 in melanoma
JS Khalili, S Liu, TG Rodríguez-Cruz, M Whittington, S Wardell, C Liu, ...
Clinical Cancer Research 18 (19), 5329-5340, 2012
Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model
T Fujiwara, DW Cai, RN Georges, T Mukhopadhyay, EA Grimm, JA Roth
JNCI: Journal of the National Cancer Institute 86 (19), 1458-1462, 1994
A Retroviral Wild-type p53 Expression Vector Penetrates Human Lung Cancer Spheroids and Inhibits Growth by Inducing Apoptosis
T Fujiwara, EA Grimm, T Mukhopadhyay, DW Cai, LB Owen-Schaub, ...
Cancer research 53 (18), 4129-4133, 1993
Mechanism of cell-mediated cytotoxicity at the single cell level: I. Estimation of cytotoxic T lymphocyte frequency and relative lytic efficiency
E Grimm, B Bonavida
The Journal of Immunology 123 (6), 2861-2869, 1979
Clinical Correlates of NRAS and BRAF Mutations in Primary Human Melanoma
JA Ellerhorst, VR Greene, S Ekmekcioglu, CL Warneke, MM Johnson, ...
Clinical Cancer Research 17 (2), 229-235, 2011
The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells.
M TsUDO, CK Goldman, KF Bongiovanni, WC Chan, EF Winton, M Yagita, ...
Proceedings of the National Academy of Sciences 84 (15), 5394-5398, 1987
Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer …
AW Tong, J Nemunaitis, D Su, Y Zhang, C Cunningham, N Senzer, ...
Molecular therapy 11 (1), 160-172, 2005
Genome-wide association study identifies novel loci predisposing to cutaneous melanoma
CI Amos, LE Wang, JE Lee, JE Gershenwald, WV Chen, S Fang, R Kosoy, ...
Human molecular genetics 20 (24), 5012-5023, 2011
Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival
S Ekmekcioglu, J Ellerhorst, CM Smid, VG Prieto, M Munsell, AC Buzaid, ...
Clinical Cancer Research 6 (12), 4768-4775, 2000
The system can't perform the operation now. Try again later.
Articles 1–20